Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dopamine hydrochloride |
Is a |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine adverse reaction |
Causative agent (attribute) |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine measurement, urine (procedure) |
Component |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine measurement, blood (procedure) |
Component |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine/creatinine ratio measurement (procedure) |
Component |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
24 hour urine free dopamine output measurement |
Component |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urine free dopamine measurement |
Component |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine in Glucose 800micrograms/mL intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine measurement |
Component |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine hydrochloride 400mg/glucose infusion solution 250mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine hydrochloride 800mg/glucose infusion solution 250mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pramipexole (substance) |
Is a |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cabergoline |
Is a |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bromocriptine (substance) |
Is a |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levodopa (substance) |
Is a |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apomorphine (substance) |
Is a |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine preparation |
Is a |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dopamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Quinagolide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Quinagolide 25micrograms tablet and 50micrograms tablet starter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely quinagolide 75 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergoline derivative-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine hydrochloride 40mg/mL injection solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine hydrochloride 80mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine hydrochloride 40mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine hydrochloride 80mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine hydrochloride 40mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|